Cindy Shaw

CRISPR/Cas9-mediated KLKB1 Gene Editing and Serum Kallikrein Reduction by NTLA-2002 Remains Durable in Humanized Mice Following Liver Regeneration after Partial Hepatectomy

P. Cottingham, C. Blanchard, Jessica Seitzer, 2022, Journal of Allergy and Clinical Immunology.